Quiz|Articles|November 20, 2026

OncLive Weekly News Quiz (11/20/2026): Did You Miss Crucial Lung Cancer, PCNSL, Gastroesophageal Cancer, and AML Updates?

Author(s)OncLive Staff
Fact checked by: Chris Ryan

Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.

The FDA granted accelerated approval to neladalkib (Nelkarmi) for locally advanced or metastatic ALK-positive non–small cell lung cancer based on data from the phase 1/2 ALKOVE-1 trial (NCT05384626). Patients previously treated with which single ALK-directed TKI are included in the indication?



Related to this article